Health Technology/clinical-trials

Belgian Mobile Health Trial Tests Cardio2U App for Atrial Fibrillation and Heart Failure Follow-up — Digital Care Revolution Under Study

247 Health News Editorial

·

14 May 2026

·

3 min read

·clinical-trials

Belgian researchers are testing the Cardio2U mobile application for long-term follow-up of patients with atrial fibrillation and heart failure. This 200-participant study evaluates usability, patient satisfaction, and adherence to app-driven cardiac care through 2026.

Originally reported by ClinicalTrials.gov

References

  1. 1.University Hospital, Antwerp. (2024). Long-term Evaluation of a Mobile Application for Follow-up of Cardiac Patients. ClinicalTrials.gov. NCT05951088. https://clinicaltrials.gov/study/NCT05951088
  2. 2.Colilla, S., Crow, A., Petkun, W., Singer, D. E., Simon, T., & Liu, X. (2013). Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. American Journal of Cardiology, 112(8), 1142-1147. https://doi.org/10.1016/j.amjcard.2013.05.063
  3. 3.Heidenreich, P. A., Albert, N. M., Allen, L. A., Bluemke, D. A., Butler, J., Fonarow, G. C., ... & Trogdon, J. G. (2013). Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circulation: Heart Failure, 6(3), 606-619. https://doi.org/10.1161/HHF.0b013e318291329a
  4. 4.Savarese, G., & Lund, L. H. (2017). Global public health burden of heart failure. Cardiac Failure Review, 3(1), 7-11. https://doi.org/10.15420/cfr.2016:25:2
  5. 5.Kitsiou, S., Paré, G., Jaana, M., & Gerber, B. (2017). Effectiveness of mHealth interventions for patients with diabetes: an overview of systematic reviews. PLoS One, 12(3), e0173160. https://doi.org/10.1371/journal.pone.0173160
  6. 6.Australian Digital Health Agency. (2023). Digital Health Strategy for Australia. Australian Government Department of Health. https://www.digitalhealth.gov.au/
Share:XLinkedIn
2

247 Health News Editorial

247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service